Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lorraine A, Soisson"'
Autor:
Barnabas G. Williams, Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk, Robert J. Ragotte, Hannah Davies, Jordan R. Barrett, Kirsty McHugh, Cassandra A. Rigby, Daniel G. W. Alanine, Lea Barfod, Michael W. Shea, Li An Cowley, Rebecca A. Dabbs, David J. Pattinson, Alexander D. Douglas, Oliver R. Lyth, Joseph J. Illingworth, Jing Jin, Cecilia Carnrot, Vinayaka Kotraiah, Jayne M. Christen, Amy R. Noe, Randall S. MacGill, C. Richter King, Ashley J. Birkett, Lorraine A. Soisson, Katherine Skinner, Kazutoyo Miura, Carole A. Long, Matthew K. Higgins, Simon J. Draper
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) and RH5-interacting protein (RIPR) to form an essential heterotrimeri
Externí odkaz:
https://doaj.org/article/c0357f954cd04ff984155d03439a386e
Autor:
Mark D. Langowski, Farhat A. Khan, Sofya Savransky, Dallas R. Brown, Arasu Balasubramaniyam, William B. Harrison, Xiaoyan Zou, Zoltan Beck, Gary R. Matyas, Jason A. Regules, Robin Miller, Lorraine A. Soisson, Adrian H. Batchelor, Sheetij Dutta
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-11 (2022)
Abstract The Circumsporozoite Protein (CSP) of Plasmodium falciparum contains an N-terminal region, a conserved Region I (RI), a junctional region, 25–42 copies of major (NPNA) and minor repeats followed by a C-terminal domain. The recently approve
Externí odkaz:
https://doaj.org/article/0da9d7df686a4d03baf0a5d54ff2c7f7
Autor:
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, Martha Sedegah, Keith Limbach, Nimfa Teneza-Mora, Ilin Chuang, K Monique Hollis-Perry, Jo Glenna Banania, Ivelese Guzman, Harini Ganeshan, Sharina Reyes, Michael R Hollingdale, Mimi Wong, Ashley Lindstrom, Anatalio Reyes, Yolanda Alcorta, Lindsey Garver, Kelli Bankard, Arnel Belmonte, Maria Belmonte, Jun Huang, Kalpana Gowda, Sandra Inoue, Rachel Velasco, Elke Bergmann-Leitner, Jack Hutter, Tida Lee, Nehkonti Adams, Sidhartha Chaudhury, Devin Hunt, Cindy Tamminga, Eleanor Berrie, Duncan Bellamy, Mustapha Bittaye, Katie Ewer, Carter Diggs, Lorraine A Soisson, Alison Lawrie, Adrian Hill, Thomas L Richie, Eileen Villasante, Judith E Epstein, Christopher A Duplessis
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256980 (2021)
BackgroundA DNA-prime/human adenovirus serotype 5 (HuAd5) boost vaccine encoding Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP) and Pf apical membrane antigen-1 (PfAMA1), elicited protection in 4/15 (27%) of subjects against controlled h
Externí odkaz:
https://doaj.org/article/4dc547617946467c9611eaa99d4458b4
Autor:
Jack N Hutter, Paul M. Robben, Christine Lee, Melinda Hamer, James E. Moon, Kristen Merino, Lei Zhu, Heather Galli, Xiaofei Quinn, Dallas R. Brown, Elizabeth Duncan, Jessica Bolton, Xiaoyan Zou, Evelina Angov, David E. Lanar, Mangala Rao, Gary R. Matyas, Zoltan Beck, Elke Bergmann-Leitner, Lorraine A. Soisson, Norman C. Waters, Viseth Ngauy, Jason Regules, Sheetij Dutta
Publikováno v:
Vaccine. 40(40)
The global burden of malaria remains substantial. Circumsporozoite protein (CSP) has been demonstrated to be an effective target antigen, however, improvements that offer more efficacious and more durable protection are still needed. In support of re
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 107:1356
Autor:
Bernhards R Ogutu, Odika J Apollo, Denise McKinney, Willis Okoth, Joram Siangla, Filip Dubovsky, Kathryn Tucker, John N Waitumbi, Carter Diggs, Janet Wittes, Elissa Malkin, Amanda Leach, Lorraine A Soisson, Jessica B Milman, Lucas Otieno, Carolyn A Holland, Mark Polhemus, Shon A Remich, Christian F Ockenhouse, Joe Cohen, W Ripley Ballou, Samuel K Martin, Evelina Angov, V Ann Stewart, Jeffrey A Lyon, D Gray Heppner, Mark R Withers, MSP-1 Malaria Vaccine Working Group
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the FMP1/AS02 c
Externí odkaz:
https://doaj.org/article/656dad9481c241c485519a092be610e9
Autor:
Bernhards R, Ogutu, Odika J, Apollo, Denise, McKinney, Willis, Okoth, Joram, Siangla, Filip, Dubovsky, Kathryn, Tucker, John N, Waitumbi, Carter, Diggs, Janet, Wittes, Elissa, Malkin, Amanda, Leach, Lorraine A, Soisson, Jessica B, Milman, Lucas, Otieno, Carolyn A, Holland, Mark, Polhemus, Shon A, Remich, Christian F, Ockenhouse, Joe, Cohen, W Ripley, Ballou, Samuel K, Martin, Evelina, Angov, V Ann, Stewart, Jeffrey A, Lyon, D Gray, Heppner, Mark R, Withers, Mark, Fukuda
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
Objective The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the F